Scientists make biodegradable pharmaceuticals
9 September 2015 | By Victoria White
Scientists from Leuphana University Lüneburg have developed a way to make drugs that break down into harmless compounds before they contaminate our water supply...
List view / Grid view
News
TxCell announces preclinical efficacy results for Col-Treg in autoimmune uveitis
9 September 2015 | By Victoria White
In vivo administration of Col-Treg in the model of autoimmune uveitis significantly inhibited clinical symptoms, retinal tissue lesions as well as ocular proinflammatory cell infiltration...
Testicular cancer found to be ‘strongly heritable’
9 September 2015 | By Victoria White
New research suggests genetic inheritance is much more important in testicular cancer than in most other cancer types, where genetics typically accounts for less than 20% of risk...
Researchers win EBF funding to advance Wolfram syndrome project
8 September 2015 | By Victoria White
A University of Birmingham research team, developing a treatment for Wolfram Syndrome, has secured £17,000 from the Enterprising Birmingham Fund...
AMRA and Pfizer team up for MR imaging project
8 September 2015 | By Victoria White
AMRA will collaborate with Pfizer to help provide a better understanding of the relationship between body composition and risk for obesity related diseases...
Pierre Fabre and Addex sign early-stage agreement in CNS field
8 September 2015 | By Victoria White
Addex Therapeutics has granted an option to license its metabotropic glutamate receptor subtype 3 (mGlu3 receptor) programme to Pierre Fabre...
ReViral announces $21m fundraising to advance RSV drug
8 September 2015 | By Victoria White
The funding will enable ReViral to progress its lead drug candidate, RV521, into proof of concept clinical trials and to continue the development of a novel series of antiviral inhibitors...
Kymab on Sunday Times Tech Track ‘Ones to Watch’ list
7 September 2015 | By Victoria White
The ranking recognises Kymab’s potential for rapid future sales growth and increasing international presence...
Immunocore ranks high in the Sunday Times Hiscox Tech Track 100
7 September 2015 | By Victoria White
Immunocore has been ranked as the Number one company in the southeast region of the UK and number nine overall in the Sunday Times Hiscox Tech Track 100...
Inhaled dosage form of BAL30072 to be formulated for patients with cystic fibrosis
7 September 2015 | By Victoria White
Basilea is to work with the iABC consortium to develop an inhaled formulation of its antibiotic BAL30072 as part of a new Europe-wide programme...
Wasp venom toxin MP1 blasts holes in cancer cells
4 September 2015 | By Victoria White
Research reveals exactly how the Polybia paulista wasp's venom toxin - called MP1 - selectively kills cancer cells without harming normal cells...
In conversation – Thoughts on the current status of the sequencing industry. An interview with Jacqueline Boultwood, University of Oxford
4 September 2015 | By Oxford Global
In the run up to our 2015 Next Generation Sequencing Congress, Single Cell Congress & Genome Editing Congress we spoke with Jacqueline Boultwood, University of Oxford, a confirmed speaker at the congress, about her thoughts on the current status of the sequencing industry...
Final agenda is now available for our 2nd Annual Drug Discovery USA Congress in Boston
4 September 2015 | By Oxford Global
Production is now complete for the 2nd Annual Drug Discovery USA Congress taking place on the 29th & 30th of October 2015 in Boston, USA...
Aspirin could boost cancer immunotherapy
4 September 2015 | By Victoria White
Researchers have shown that combining immunotherapy with aspirin or other COX inhibitors substantially slowed bowel and melanoma skin cancer growth in mice...
Another step closer to cheap synthetic antivenoms
4 September 2015 | By Victoria White
Researchers have successfully identified the exact composition of sea snake venom, which makes the future development of synthetic antivenoms more realistic...
